US Stock MarketDetailed Quotes

Cullinan Therapeutics (CGEM)

Watchlist
  • 13.220
  • +0.270+2.08%
Close Apr 24 16:00 ET
  • 13.220
  • 0.0000.00%
Post 17:02 ET
800.16MMarket Cap-3.93P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cullinan Therapeutics (CGEM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
22.71%241.65M
0.38%55.26M
13.80%55.6M
51.51%75.8M
27.93%55M
3.29%196.92M
21.02%55.05M
9.04%48.86M
33.03%50.03M
-31.50%42.99M
Selling and administrative expenses
0.43%54.25M
-15.40%12.31M
2.08%13.63M
7.26%14.77M
9.67%13.54M
27.12%54.02M
36.84%14.56M
21.55%13.35M
34.80%13.77M
15.79%12.34M
-General and administrative expense
0.43%54.25M
-15.40%12.31M
2.08%13.63M
7.26%14.77M
9.67%13.54M
27.12%54.02M
36.84%14.56M
21.55%13.35M
34.80%13.77M
15.79%12.34M
Research and development costs
31.14%187.4M
6.06%42.95M
18.20%41.97M
68.32%61.03M
35.28%41.46M
-3.55%142.9M
16.20%40.49M
4.98%35.51M
32.38%36.26M
-41.17%30.65M
Operating profit
-22.71%-241.65M
-0.38%-55.26M
-13.80%-55.6M
-51.51%-75.8M
-27.93%-55M
-3.29%-196.92M
-21.02%-55.05M
-9.04%-48.86M
-33.03%-50.03M
31.50%-42.99M
Net non-operating interest income expense
-25.11%22.21M
-38.56%4.62M
-39.25%5.09M
-26.60%5.92M
15.58%6.58M
37.14%29.66M
26.96%7.51M
42.59%8.38M
51.65%8.07M
26.29%5.69M
Non-operating interest income
-25.11%22.21M
-38.56%4.62M
-39.25%5.09M
-26.60%5.92M
15.58%6.58M
37.14%29.66M
26.96%7.51M
42.59%8.38M
51.65%8.07M
26.29%5.69M
Other net income (expense)
-122.61%-443K
-1,250.00%-69K
-21.35%-108K
-151.39%-181K
-93.18%-85K
1.00%-199K
105.13%6K
65.77%-89K
-204.35%-72K
-141.12%-44K
Special income (charges)
----
----
----
----
----
--0
--0
--0
----
----
-Less:Impairment of capital assets
----
----
----
----
----
--0
--0
--0
----
----
Other non- operating income (expenses)
-122.61%-443K
-1,250.00%-69K
-21.35%-108K
-151.39%-181K
-93.18%-85K
-183.26%-199K
105.13%6K
-149.44%-89K
-204.35%-72K
-141.12%-44K
Income before tax
-31.30%-219.88M
-6.70%-50.71M
-24.78%-50.61M
-66.69%-70.06M
-29.89%-48.5M
1.04%-167.46M
-19.77%-47.53M
-3.51%-40.56M
-30.47%-42.03M
35.78%-37.34M
Income tax
0
100.83%117K
Net income
-31.21%-219.88M
-6.43%-50.71M
-24.78%-50.61M
-66.69%-70.06M
-29.89%-48.5M
-8.04%-167.58M
-86.39%-47.65M
-3.51%-40.56M
-30.47%-42.03M
35.78%-37.34M
Net income continuous Operations
-31.21%-219.88M
-6.43%-50.71M
-24.78%-50.61M
-66.69%-70.06M
-29.89%-48.5M
-8.04%-167.58M
-86.39%-47.65M
-3.51%-40.56M
-30.47%-42.03M
35.78%-37.34M
Minority interest income
0
0
0
0
0
90.10%-192K
0
0
0
-7.26%-192K
Net income attributable to the parent company
-31.36%-219.88M
-6.43%-50.71M
-24.78%-50.61M
-66.69%-70.06M
-30.56%-48.5M
-9.28%-167.38M
-100.17%-47.65M
-3.51%-40.56M
-30.47%-42.03M
35.91%-37.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-31.36%-219.88M
-6.43%-50.71M
-24.78%-50.61M
-66.69%-70.06M
-30.56%-48.5M
-9.28%-167.38M
-100.17%-47.65M
-3.51%-40.56M
-30.47%-42.03M
35.91%-37.15M
Basic earnings per share
-20.86%-3.36
-5.48%-0.77
-22.22%-0.77
-57.35%-1.07
1.33%-0.74
13.40%-2.78
-1,116.67%-0.73
30.77%-0.63
17.07%-0.68
47.18%-0.75
Diluted earnings per share
-20.86%-3.36
-5.48%-0.77
-22.22%-0.77
-57.35%-1.07
1.33%-0.74
13.40%-2.78
-1,116.67%-0.73
30.77%-0.63
17.07%-0.68
47.18%-0.75
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 22.71%241.65M0.38%55.26M13.80%55.6M51.51%75.8M27.93%55M3.29%196.92M21.02%55.05M9.04%48.86M33.03%50.03M-31.50%42.99M
Selling and administrative expenses 0.43%54.25M-15.40%12.31M2.08%13.63M7.26%14.77M9.67%13.54M27.12%54.02M36.84%14.56M21.55%13.35M34.80%13.77M15.79%12.34M
-General and administrative expense 0.43%54.25M-15.40%12.31M2.08%13.63M7.26%14.77M9.67%13.54M27.12%54.02M36.84%14.56M21.55%13.35M34.80%13.77M15.79%12.34M
Research and development costs 31.14%187.4M6.06%42.95M18.20%41.97M68.32%61.03M35.28%41.46M-3.55%142.9M16.20%40.49M4.98%35.51M32.38%36.26M-41.17%30.65M
Operating profit -22.71%-241.65M-0.38%-55.26M-13.80%-55.6M-51.51%-75.8M-27.93%-55M-3.29%-196.92M-21.02%-55.05M-9.04%-48.86M-33.03%-50.03M31.50%-42.99M
Net non-operating interest income expense -25.11%22.21M-38.56%4.62M-39.25%5.09M-26.60%5.92M15.58%6.58M37.14%29.66M26.96%7.51M42.59%8.38M51.65%8.07M26.29%5.69M
Non-operating interest income -25.11%22.21M-38.56%4.62M-39.25%5.09M-26.60%5.92M15.58%6.58M37.14%29.66M26.96%7.51M42.59%8.38M51.65%8.07M26.29%5.69M
Other net income (expense) -122.61%-443K-1,250.00%-69K-21.35%-108K-151.39%-181K-93.18%-85K1.00%-199K105.13%6K65.77%-89K-204.35%-72K-141.12%-44K
Special income (charges) ----------------------0--0--0--------
-Less:Impairment of capital assets ----------------------0--0--0--------
Other non- operating income (expenses) -122.61%-443K-1,250.00%-69K-21.35%-108K-151.39%-181K-93.18%-85K-183.26%-199K105.13%6K-149.44%-89K-204.35%-72K-141.12%-44K
Income before tax -31.30%-219.88M-6.70%-50.71M-24.78%-50.61M-66.69%-70.06M-29.89%-48.5M1.04%-167.46M-19.77%-47.53M-3.51%-40.56M-30.47%-42.03M35.78%-37.34M
Income tax 0100.83%117K
Net income -31.21%-219.88M-6.43%-50.71M-24.78%-50.61M-66.69%-70.06M-29.89%-48.5M-8.04%-167.58M-86.39%-47.65M-3.51%-40.56M-30.47%-42.03M35.78%-37.34M
Net income continuous Operations -31.21%-219.88M-6.43%-50.71M-24.78%-50.61M-66.69%-70.06M-29.89%-48.5M-8.04%-167.58M-86.39%-47.65M-3.51%-40.56M-30.47%-42.03M35.78%-37.34M
Minority interest income 0000090.10%-192K000-7.26%-192K
Net income attributable to the parent company -31.36%-219.88M-6.43%-50.71M-24.78%-50.61M-66.69%-70.06M-30.56%-48.5M-9.28%-167.38M-100.17%-47.65M-3.51%-40.56M-30.47%-42.03M35.91%-37.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -31.36%-219.88M-6.43%-50.71M-24.78%-50.61M-66.69%-70.06M-30.56%-48.5M-9.28%-167.38M-100.17%-47.65M-3.51%-40.56M-30.47%-42.03M35.91%-37.15M
Basic earnings per share -20.86%-3.36-5.48%-0.77-22.22%-0.77-57.35%-1.071.33%-0.7413.40%-2.78-1,116.67%-0.7330.77%-0.6317.07%-0.6847.18%-0.75
Diluted earnings per share -20.86%-3.36-5.48%-0.77-22.22%-0.77-57.35%-1.071.33%-0.7413.40%-2.78-1,116.67%-0.7330.77%-0.6317.07%-0.6847.18%-0.75
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -